← FDA Drug Approvals (Drugs@FDA)
TOFACITINIB CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORIENT PHARMA · Approved 2026-06-09
Drug application
- FDA Application #
ANDA219830- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOFACITINIB CITRATE
- Generic name
- TOFACITINIB
- Active ingredients
- TOFACITINIB CITRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ORIENT PHARMA
- Manufacturer
- Orient Pharma Co., Ltd. Yunlin Plant
- First approval
- 2026-06-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown